Novartis faces setbacks in drug trial pipeline

Novartis encountered difficulties in recent clinical trials, raising questions about the future growth of its pharmaceutical pipeline. Investors are monitoring the company's ability to deliver new treatments amidst these challenges.

11 Sept, 22:42 — 11 Sept, 22:42

Post Share

Sources

Showing 1 of 2 sources

Barron'sHigh1d ago

Novartis: More Pain on the Way? - Barron's

Novartis: More Pain on the Way? Barron's

Read full article →

Coverage Timeline

First report: Yahoo · 11 Sept, 15:10|Full coverage: 2 · 8h|Window: 8h

Left-leaningCenterRight-leaning

Yahoo11 Sept, 15:10First to report

Drug Trial Setbacks Raise Questions Over Novartis (NVS)’s Growth Pipeline

8h later

Barron's11 Sept, 22:42Latest update

Novartis faces setbacks in drug trial pipeline

Sources

Novartis: More Pain on the Way? - Barron's

Coverage Timeline

Drug Trial Setbacks Raise Questions Over Novartis (NVS)’s Growth Pipeline

Novartis: More Pain on the Way? - Barron's

Related Stories

Ebola Cases Surpass 7,000 in Congo Amid New Outbreak Spread

Health Risks Linked to Hot Beverages and Prolonged Sitting

Ebola cases surpass 7,000 in DR Congo as virus spreads to new province

UK Parliament Rejects Bill to Legalize Assisted Dying for Terminally Ill